Cross Site Scripting vulnerability in the web application
21Vexday Risk Score
No sign of exploitation. No public exploitation artifact known so far.
ssvc Trackcvss 7.6epss 0.3%
exploitation probability
0.3%top 82% of all CVEs
observed exploitation
nono source reports it
HCL MyXalytics product is affected by Cross Site Scripting vulnerability in the web application. This can allow the execution of unauthorized scripts, potentially resulting in unauthorized actions or access.
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:U/C:H/I:L/A:H
Affected products
HCL · HCL MyXalytics